Investigating genetic factors linked to preeclampsia in mothers and their babies
Clinical and functional follow-up of maternal and fetal preeclampsia genetic risk loci
This study is looking at how genes might affect the chances of developing preeclampsia during pregnancy, which can cause high blood pressure and other issues, to help find better ways to predict and treat this condition for moms and their babies.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11080544 on NIH RePORTER |
What this research studies
This research focuses on understanding the genetic risk factors associated with preeclampsia, a serious pregnancy condition characterized by high blood pressure and protein in the urine. By analyzing genetic data from mothers and their fetuses, the study aims to identify specific genetic loci that contribute to the risk of developing preeclampsia. The findings could lead to better predictive tools and therapeutic options for managing this condition, ultimately improving maternal and fetal health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for participation include pregnant women with a history of preeclampsia or those who are at high risk for developing the condition.
Not a fit: Patients who are not pregnant or those without a history of preeclampsia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved screening and treatment options for women at risk of preeclampsia, enhancing both maternal and fetal health.
How similar studies have performed: Previous research has successfully identified genetic risk factors for preeclampsia, suggesting that this approach has potential for meaningful advancements in understanding the condition.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Gray, Kathryn Johnson — University of Washington
- Study coordinator: Gray, Kathryn Johnson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.